Association of dysanapsis with mortality among older adults

Motahareh Vameghestahbanati, Coralynn Sack, Artur Wysoczanski, Eric A. Hoffman, Elsa Angelini, Norrina B. Allen, Alain G. Bertoni, Junfeng Guo, David R. Jacobs, Joel D. Kaufman, Andrew Laine, Ching Long Lin, Daniel Malinsky, Erin D. Michos, Elizabeth C. Oelsner, Steven J. Shea, Karol E. Watson, Andrea Benedetti, R. Graham Barr, Benjamin M. Smith

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish (US)
Article number2300551
JournalEuropean Respiratory Journal
Issue number6
StatePublished - 2023

Bibliographical note

Funding Information:
Support statement: This research was supported by R01-HL130506, R01-HL077612, R01-093081, R01-HL155816, R01-HL121270, K23ES030725, K25ES034064, contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, by grants UL1-TR-000040, UL1-TR-001079 and UL1-TR-001420 from the National Center for Advancing Translational Sciences (NCATS) and by the American Lung Association. M. Vameghestahbanati was supported by Vanier Canada Graduate Scholarship. The information contained herein was derived in part from data provided by the Bureau of Vital Statistics, New York City Department of Health, and Mental Hygiene. This publication was developed under STAR research assistance agreements, numbers RD831697 (MESA Air) and RD-83830001 (MESA Air Next Stage), awarded by the US Environmental Protection Agency. It has not been formally reviewed by the EPA. The views expressed in this document are solely those of the authors and the EPA does not endorse any products or commercial services mentioned in this publication. Funding information for this article has been deposited with the Crossref Funder Registry.

Funding Information:
Conflict of interest: C. Sack reports grants from NIEHS K23ES030725-04, outside the submitted work. E.A. Hoffman reports support for the present manuscript from NIH; E.A. Hoffman also reports that he is founder and shareholder of VIDA Diagnostics, and an unpaid member of Photon Counting CT advisory board for Siemens Healthineers, outside the submitted work. N.B. Allen reports support for the present manuscript from NIH/NHLBI; N.B. Allen also reports grants from NIH/NHLBI, outside the submitted work. J. Guo reports support for the present manuscript from National Institutes of Health; J. Guo also reports being a shareholder of VIDA Diagnostics, outside the submitted work. E.D. Michos reports advisory board participation with AstraZeneca, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk and Pfizer, outside the submitted work. S.J. Shea reports support for the present manuscript from the National Heart, Lung, and Blood Institute. R.G. Barr reports support for the present manuscript from NIH, COPD Foundation and Foundation for the NIH; R.G. Barr also reports grants from American Lung Association, and advisory board participation with COPD Foundation, outside the submitted work. B.M. Smith reports support for the present manuscript from NIH, Canadian Lung Association, CIHR and Quebec Health Research Fund. All other authors have no potential conflicts of interest to disclose.

PubMed: MeSH publication types

  • Letter
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

Cite this